This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

SAVINGS DEADLINE EXPIRES:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Delivered as Hybrid Event from 16-18 November 2022
Live In-Person Conference Delivered 16-18 NovemberAustria Center Vienna

Daniel Sejer Pedersen, PhD
Senior Development Scientist, Chemical Development at Novo Nordisk

Profile

Daniel Sejer Pedersen obtained his PhD degree in synthetic organic chemistry from Cambridge University in 2005 and has held a variety of positions at universities and in industry. Since 2018 he has been employed as a Senior Development Scientist in Chemical Development at Novo Nordisk focusing on development of phase 3 processes and the assessment and development of new manufacturing technologies.

Agenda Sessions

  • Green Solid-Phase Peptide Synthesis: From Idea to Phase 3 Production

    11:00